Vogli 300 mcg (Tablet)

Product Information

• Vogli
• Alpha-Glucosidase Inhibitor
• Medicine for Diabetes Mellitus
• Voglibose Tablets
• Oral Hypoglycaemic Agents
• Post-Prandial Hyperglycaemia (PPHG) Reduction
• Immunotherapy for Non-Insulin-Dependent Diabetes Mellitus (NIDDM)
• Combination Therapy with Other OHAs
• Prevention of Type 2 Diabetes Mellitus Onset
• Elderly Patient Use
• Usage in Hepatic Dysfunction
• Usage in Mild to Moderate Renal Impairments
• Glycogen Storage Disease Prevention
• Non-Diabetic Hyperinsulinemia Treatment
• Steroid Induced Diabetes Mellitus Treatment
• Selective α-Glucosidase Inhibition
• Delay in Carbohydrate Digestion and Absorption
• Plasma Glucose Suppression
• Dosage: 0.2 mg Tablets
• Dosing Frequency: 3 Times a Day
• Initial Dose Adjustment
• Pediatric Use Caution
• Geriatric Use Caution
• Safety in Pregnancy Not Established
• Lactation Advisory
• Careful Administration with Other Antidiabetic Drugs
• Contraindicated in Diabetic Ketoacidosis
• Contraindicated in Severe Infection or Trauma
• Contraindicated in Gastrointestinal Obstruction
• Possible Side Effects: Diarrhoea, Abdominal Pain, Constipation, Nausea, Vomiting, Gas, Intestinal Obstruction-like Symptoms, Hypoglycaemia, Hepatic Dysfunction, Jaundice, Anaemia, Numbness, Edema, Blurred Vision, Hyperkalemia
• Interaction with Antidiabetic Drugs
• Interaction with Drugs Affecting Hypoglycaemic Action
• Implications for Antidiabetic Drug Therapy
• Precautions for Patients with History of Laparotomy
• Precautions for Patients with Chronic Intestinal Disease
• Precautions for Patients with Serious Hepatic Dysfunction
• Precautions for Patients with Serious Renal Dysfunction
• Special Considerations for Elderly Patients
• Dosage Consideration in Renal Failure
• No Hypoglycaemia in Vogli Overdose
• Transient Overdose Effects: Flatulence, Diarrhoea, Abdominal Discomfort
• Cool and Dry Storage Conditions
• Protect from Light

Related Brands